The AIM with Immunotherapy Initiative – Home › Forums › Immunotherapy › Dosing and administration › Infusion times › Reply To: Infusion times
February 2, 2018 at 10:20 pm
#4653
Anonymous
We are still administering ipilimumab over 90 min and nivolumab over 60 min. However, I believe that we are in the process of changing the infusion time for nivolumab to 30 minutes across the institution.